Capital Performance Advisors »

Cogent Biosciences shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $399 37 10.81

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Cogent Biosciences

Point72 Asset Management
Kynam Capital Management
BlackRock
Commodore Capital
BlackRock
TCG Crossover Management
Fairmount Funds Management
VR Adviser
Vanguard Group
Paradigm Biocapital Advisors
Redmile Group
State Street Corporation
Deerfield Management Company
Geode Capital Management
Sofinnova Ventures

View all funds holding Cogent Biosciences